This is a preview of subscription content, log in via an institution to check access.
Reference
Butt T, et al. Modelling Cost Effectiveness in Neovascular Age-Related Macular Degeneration: The Impact of Using Contrast Sensitivity vs. Visual Acuity. Applied Health Economics and Health Policy : 8 Mar 2014. Available from: URL: http://dx.doi.org/10.1007/s40258-014-0090-0
Additional information
* Bevacizumab for neovascular age related macular degeneration
Rights and permissions
About this article
Cite this article
How visual function is measured affects CEA results in wet AMD. PharmacoEcon Outcomes News 699, 6 (2014). https://doi.org/10.1007/s40274-014-1136-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1136-0